Novel combinations such as BET inhibitors with SMAC mimetics (SMACm) in PDAC models synergistically inhibit tumor growth, induce multiple cell death pathways, and remodel the immunosuppressive tumor microenvironment to enhance anti-tumor immunity (188). This evidence concerns the gene DNER and neoplasm.